EMV.AX
Price:
$1.95
Market Cap:
$166.76M
EMvision Medical Devices Limited, a medical device company, engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for stroke diagnosis, monitoring, as well as other medical imaging needs. The company was incorporated in 2017 and is based in Macquarie Park, Australia.
Industry
Medical - Devices
IPO Date
2018-12-12
Stock Exchange
ASX
Ticker
EMV.AX
According to EMVision Medical Devices Ltd’s latest financial reports and current stock price. The company's current ROE is -36.49%. This represents a change of 45.76% compared to the average of -25.03% of the last 4 quarters.
The mean historical ROE of EMVision Medical Devices Ltd over the last ten years is -64.79%. The current -36.49% ROE has changed -43.68% with respect to the historical average. Over the past ten years (40 quarters), EMV.AX's ROE was at its highest in in the December 2017 quarter at 0%. The ROE was at its lowest in in the June 2023 quarter at -60.84%.
Average
-64.79%
Median
-66.06%
Minimum
-86.27%
Maximum
-14.74%
Discovering the peaks and valleys of EMVision Medical Devices Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 32.76%
Maximum Annual ROE = -14.74%
Minimum Annual Increase = -80.52%
Minimum Annual ROE = -86.27%
Year | ROE | Change |
---|---|---|
2024 | -14.74% | -80.52% |
2023 | -75.67% | -12.29% |
2022 | -86.27% | 3.28% |
2021 | -83.54% | 32.76% |
2020 | -62.92% | -2.13% |
2019 | -64.29% | -2.69% |
The current ROE of EMVision Medical Devices Ltd (EMV.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-58.90%
5-year avg
-64.63%
10-year avg
-64.79%
EMVision Medical Devices Ltd’s ROE is greater than Mach7 Technologies Limited (-10.01%), less than Recce Pharmaceuticals Ltd (247.20%), greater than Volpara Health Technologies Limited (-17.60%), greater than Medical Developments International Limited (-58.86%), greater than Micro-X Limited (-105.90%),
Company | ROE | Market cap |
---|---|---|
-10.01% | $78.40M | |
247.20% | $75.74M | |
-17.60% | $291.26M | |
-58.86% | $51.26M | |
-105.90% | $42.38M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like EMVision Medical Devices Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like EMVision Medical Devices Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is EMVision Medical Devices Ltd's ROE?
How is the ROE calculated for EMVision Medical Devices Ltd (EMV.AX)?
What is the highest ROE for EMVision Medical Devices Ltd (EMV.AX)?
What is the 3-year average ROE for EMVision Medical Devices Ltd (EMV.AX)?
What is the 5-year average ROE for EMVision Medical Devices Ltd (EMV.AX)?
How does the current ROE for EMVision Medical Devices Ltd (EMV.AX) compare to its historical average?